-- 
FDA Committee Meets on Teva's Azilect (Part 2)

-- B y  
-- 
2011-10-17T18:18:57Z

-- http://www.bloomberg.com/news/2011-10-17/fda-committee-meets-on-teva-s-azilect-part-2-video-.html
A U.S. Food and Drug Administration
advisory committee meets to discuss a supplemental new drug 
application for Teva Pharmaceutical Inc.'s Azilect, for the 
proposed indication of treating patients with idiopathic (of 
unknown cause) Parkinson's disease to slow clinical progression 
and treat the symptoms of the disease as initial monotherapy and
as adjunct therapy to levodopa. (This is an excerpt and the 
second part of the meeting. Source: Bloomberg)  00:00 FDA presentations on Teva's Azilect
48:41 FDA presenters respond to questions.  Running time 59:38
 